Home » Canada Releases Guidance on Submission of Pharmacogenomic Information
Canada Releases Guidance on Submission of Pharmacogenomic Information
March 6, 2007
Health Canada has published final guidance for manufacturers on how and when to submit pharmacogenomic (PGx) information in support of an application for a medical device, drug or biologic product intended for human use.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor